Post-Transplant Guidelines for Patients and Physicians

A Guide to Protecting Your Health after Transplant: Recommended Tests and Procedures provides guidelines that patients and their physicians can use to schedule long-term follow-up care after a marrow, peripheral blood stem cell (PBSC) or cord blood transplant.

The guide includes:

Patient Booklet

Physicians' Guidelines


MYELOMA TERMS YOU SHOULD KNOW
From the Leukemia and Lymphoma Society
(A small Adobe PDF file)

QUESTIONS TO ASK YOUR HEALTHCARE TEAM
From the Leukemia and Lymphoma Society
(A small Adobe PDF file)

MYELOMA GUIDE
From the International Myeloma Foundation
(An Adobe PDF file - about 2.6 MB)

Understanding Medicare Part B:
What Patients need to know about IV Therapy Reimbursement

Cynthia Sherman
Quorum consulting
(Sponsored by the IMF)
May 4, 2007

Click here for Adobe PDF format

Understanding Bone Marrow and Stem Cell Transplantation

Edward Agura, MD,
Director of the Program in Blood and Marrow Transplant
Baylor University Medical Center, Dallas, Texas
Feb. 20, 2007

Click here for Adobe PDF format


Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement

ANGELA DISPENZIERl, MD; S. VINCENT RAJKUMAR, MD et al
MAYO CLINIC
March, 2007

Click here for Adobe PDF format


Health Care Directives - Who Needs them?
- Maybe You! -

MM FIGHTER! and Attorney Bob Heller
January, 2007


Click here for Adobe PDF format (1.6 MB)

Mayo Clinic Consensus Statement for the Use of
Bisphosphonates in Multiple Myeloma

Martha Q. Lacey, MD et al
August 2006

Click here for Adobe PDF format

What can you do about the high cost of Revlimid?
Some advice from the IMF

Jaw Osteonecrosis in IV Bisposphonate Users: Why it happens and what to do about it

Dr. Dolphine Oda, University of Washington School of Dentistry, October 21, 2006

Click here for Adobe PDF format (11 MB)

Caution Urged in Bisphosphonate Use for Multiple Myeloma
Mayo Clinic College of Medicine, Aug. 25, 2006 (http://www.cancerpage.com)

Detailed Guide: What is Multiple Myeloma
American Cancer Society

Prevalence of Monoclonal Gammopathy of Undetermined Significance
Robert A. Kyle, M.D. et al

New Developments in Multiple Myeloma Management
James R. Berenson, MD.
Coping, Nov/Dec 2005, pg. 44

Return to NWMMFIGHTERS! home page